News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,904 Results
Type
Article (39145)
Company Profile (283)
Press Release (648476)
Section
Business (203904)
Career Advice (1996)
Deals (35373)
Drug Delivery (89)
Drug Development (80847)
Employer Resources (168)
FDA (16098)
Job Trends (14808)
News (344643)
Policy (32450)
Tag
Academia (2530)
Alliances (49185)
Alzheimer's disease (1257)
Approvals (16049)
Artificial intelligence (144)
Bankruptcy (352)
Best Places to Work (11581)
Biotechnology (200)
Breast cancer (188)
Cancer (1365)
Cardiovascular disease (110)
Career advice (1664)
Cell therapy (281)
Clinical research (64693)
Collaboration (482)
Compensation (260)
COVID-19 (2541)
C-suite (108)
Data (1389)
Diabetes (172)
Diagnostics (6170)
Earnings (84892)
Employer resources (146)
Events (110007)
Executive appointments (394)
FDA (16767)
Funding (426)
Gene therapy (195)
GLP-1 (597)
Government (4333)
Healthcare (18693)
Infectious disease (2633)
Inflammatory bowel disease (111)
Interviews (309)
IPO (16339)
Job creations (3625)
Job search strategy (1418)
Layoffs (418)
Legal (7861)
Lung cancer (197)
Lymphoma (98)
Manufacturing (206)
Medical device (13211)
Medtech (13216)
Mergers & acquisitions (19194)
Metabolic disorders (452)
Neuroscience (1577)
NextGen Class of 2024 (6500)
Non-profit (4467)
Northern California (1693)
Obesity (258)
Opinion (183)
Patents (117)
People (56456)
Phase I (20119)
Phase II (28494)
Phase III (21237)
Pipeline (514)
Postmarket research (2560)
Preclinical (8545)
Radiopharmaceuticals (236)
Rare diseases (259)
Real estate (5890)
Regulatory (21664)
Research institute (2310)
Resumes & cover letters (349)
Southern California (1460)
Startups (3563)
United States (15141)
Vaccines (563)
Weight loss (181)
Date
Last 7 days (580)
Last 30 days (2325)
Last 365 days (35164)
2024 (35003)
2023 (40078)
2022 (51173)
2021 (55711)
2020 (54086)
2019 (46541)
2018 (35019)
2017 (32110)
2016 (31483)
2015 (37554)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (195)
Asia (37266)
Australia (6087)
California (3809)
Canada (1449)
China (304)
Colorado (171)
Connecticut (176)
Europe (79824)
Florida (533)
Georgia (135)
Illinois (384)
Indiana (224)
Maryland (626)
Massachusetts (2959)
Michigan (172)
Minnesota (290)
New Jersey (1100)
New York (1080)
North Carolina (742)
Northern California (1693)
Ohio (146)
Pennsylvania (923)
South America (1091)
Southern California (1460)
Texas (547)
Utah (108)
Washington State (399)
687,904 Results for "arvinas inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Arvinas to Participate in Upcoming Investor Conferences
Arvinas, Inc. today announced that management will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on Thursday, June 6 in New York City.
June 3, 2024
·
2 min read
Business
Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer
Arvinas, Inc. announced the appointment of Andrew Saik to the role of Chief Financial Officer and Treasurer reporting to Chairperson, Chief Executive Officer, and President, John Houston, Ph.D.
June 24, 2024
·
6 min read
Press Releases
Arvinas to Present at Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
·
1 min read
Press Releases
Arvinas to Participate in Upcoming November 2024 Investor Conferences
November 5, 2024
·
1 min read
Pharm Country
Arvinas to Present at Upcoming May 2024 Investor Conferences
Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, announced that management will participate in two upcoming investor conferences:
May 2, 2024
·
1 min read
Business
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
Arvinas, Inc. announced the appointment of Randy Teel, Ph.D., to the newly created role of Chief Business Officer.
April 24, 2024
·
4 min read
Pharm Country
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Arvinas, Inc. announced it has entered into an exclusive strategic license agreement with Novartis for the worldwide development and commercialization of ARV-766, Arvinas’ second generation PROTAC® androgen receptor degrader for patients with prostate cancer.
April 11, 2024
·
5 min read
Press Releases
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast Cancer Symposium
November 25, 2024
·
5 min read
Business
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 7, 2024
·
16 min read
Press Releases
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
October 30, 2024
·
15 min read
1 of 68,791
Next
